Skip to main content

Global Gastrointestinal Devices Market to Witness 7% CAGR Growth on Expanding GI Screenings 2030

 


The global gastrointestinal devices market is projected to grow at a CAGR of ~7% during the forecast period. This expansion is fueled by an aging population, an increasing prevalence of gastrointestinal diseases, and a surge in minimally invasive procedures. The rise in early disease screening programs, especially for colorectal cancer, is significantly driving device adoption. However, factors such as stringent regulatory approvals and the high cost of advanced GI procedures may limit market growth in certain regions. 

Gastrointestinal (GI) devices refer to specialized instruments designed to diagnose, monitor, and treat digestive system disorders. These include endoscopic devices, biopsy forceps, enteral feeding tubes, hemostatic devices, and GI stents, among others. Their primary purpose is to provide minimally invasive solutions that improve diagnostic accuracy and therapeutic outcomes while reducing patient discomfort. The sector has witnessed continuous innovation, such as AI-powered endoscopic imaging, robotic-assisted surgeries, and advanced biodegradable stents, improving both patient care and procedural efficiency.

Click here to get our sample PDF report for Medical Devices market:
https://meditechinsights.com/gastrointestinal-devices-market/request-sample/

Increasing gastrointestinal disease burden fuelling market demand

One of the primary factors propelling the GI devices market is the growing burden of gastrointestinal diseases worldwide. Conditions such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD) are becoming more prevalent due to aging populations, dietary changes, and sedentary lifestyles. For instance, colorectal cancer remains a leading cause of cancer-related deaths, necessitating enhanced screening tools like high-definition endoscopes and AI-assisted lesion detection. Additionally, the increasing adoption of endoscopic procedures for early disease detection is driving demand for high-precision diagnostic and therapeutic devices. The trend toward outpatient and ambulatory GI procedures is also boosting market growth, as healthcare providers seek cost-effective and efficient solutions.

Technological innovations and AI-powered endoscopy driving market expansion

AI-driven advancements in gastrointestinal devices are revolutionizing diagnostics and treatment approaches. AI-powered endoscopy enhances polyp detection accuracy, reducing false-negative rates and improving early diagnosis of GI cancers. AI algorithms can analyze endoscopic images in real-time, offering decision support to physicians and improving procedural efficiency. Additionally, the development of robotic-assisted endoscopy is enhancing precision in minimally invasive GI surgeries, reducing recovery times and improving patient outcomes. Another key advancement is the adoption of single-use endoscopes, which eliminate the risk of cross-contamination and the need for costly sterilization processes. Innovations like biodegradable GI stents and 3D imaging-guided interventions further expand treatment options, making gastrointestinal procedures safer and more effective. These technological strides are enhancing clinical outcomes and accelerating market adoption across hospitals and ambulatory surgical centers.

Competitive Landscape Analysis

The global gastrointestinal devices market is marked by the presence of established and emerging market players such as Olympus Corporation; Fujifilm Holdings Corporation; Hoya Corporation (PENTAX Medical); Stryker Corporation; Boston Scientific Corporation; Medtronic Plc; Cook Group Incorporated; CONMED Corporation; Johnson & Johnson (Ethicon Inc.); and Cantel Medical Corporation among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Get PDF Report for Competitive Analysis:
https://meditechinsights.com/gastrointestinal-devices-market/request-sample/

Global Gastrointestinal Devices Market Segmentation

This report by Medi-Tech Insights provides the size of the global gastrointestinal devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type, application, and end-user.

Market Size & Forecast (2023-2030), By Product Type, USD Million

  • GI Endoscopes
  • Laparoscopes
  • Biopsy Devices
  • Endoscopic Retrograde Cholangiopancreatography (ERCP)
  • Others

Market Size & Forecast (2023-2030), By Application, USD Million

  • Diagnostic
  • Therapeutic

Market Size & Forecast (2023-2030), By End-user, USD Million

  • Hospitals
  • Diagnostic Centers
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more